Tag Archives: drugs

Pick your post-JPM buzz: Pfizer eyes Amarin, Biogen shops anyone with 'multiple' phase 3 drugs

The J.P. Morgan Healthcare Conference may be over, but that doesn’t mean the dealmaking is. Often, deals that took shape at the meeting materialize later in the year, and some recent buzz puts Pfizer and Biogen at the center of potential takeovers. Pfizer is reportedly eyeing a buyout of cardiovascular player Amarin, whose fish-oil-derived lipid drug… Read More »

J&J raises U.S. prices on around two dozen drugs

NEW YORK (Reuters) – Johnson & Johnson raised U.S. prices on around two dozen prescription drugs on Thursday, including the psoriasis treatment Stelara, prostate cancer drug Zytiga and blood thinner Xarelto, all among its top-selling products. FILE PHOTO: A Johnson & Johnson building is shown in Irvine, California, U.S., January 24, 2017. REUTERS/Mike Blake J&J… Read More »

Specialty drugs drive Rx spending increase, Blue Cross says

Dive Brief: Spending by Blue Cross Blue Shield insurers increased from 2016 to 2017 primarily through increases in spending on on specialty drugs, according to a report released Wednesday by the Blue Cross Blue Shield Association and Blue Health Intelligence. Insurers under the Blues’ umbrella, dozens of independently run payers, spent about $ 100 billion on… Read More »